Discovery ofLenacapavir: First-in-Class Twice-YearlyCapsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, John O. Link, Scott D. Schroeder et al.|Journal of Medicinal Chemistry|2025Cited by 11